2011
DOI: 10.1021/bm200700d
|View full text |Cite
|
Sign up to set email alerts
|

Osteogenic Differentiation of Pre-Osteoblasts on Biomimetic Tyrosine-Derived Polycarbonate Scaffolds

Abstract: The osteogenic potential of biomimetic tyrosine-derived polycarbonate (TyrPC) scaffolds containing either an ethyl ester or a methyl ester group combined with recombinant human bone morphogenetic protein-2 (rhBMP-2) was assessed using the preosteoblast cell line MC3T3-E1. Each composition of TyrPC was fabricated into 3D porous scaffolds with a bimodal pore distribution of micropores <20 μm and macropores between 200 and 400 μm. Scanning electron microscopy (SEM) characterization suggested MC3T3-E1 cell attachm… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
35
0

Year Published

2012
2012
2020
2020

Publication Types

Select...
6
2

Relationship

5
3

Authors

Journals

citations
Cited by 34 publications
(36 citation statements)
references
References 27 publications
1
35
0
Order By: Relevance
“…A possible explanation for the performance superiority of TyrPC-based scaffolds may be attributable to chemical and physical properties that promoted cell attachment, amplification and differentiation to an osteogenic phenotype, and degradation in register with bone regeneration, thus improving regenerative outcome with a 50 mg dose versus traditional rhBMP-2 dosing that are five times greater. 8 The minimal dose of rhBMP-2 supplementation of TyrPC scaffolds significantly enhanced bone formation. There is a profound patient benefit when a delivery system (i.e., bone biomimetic substitute) provides a physiological, calibrated dose of rhBMP-2.…”
Section: Discussionmentioning
confidence: 94%
See 1 more Smart Citation
“…A possible explanation for the performance superiority of TyrPC-based scaffolds may be attributable to chemical and physical properties that promoted cell attachment, amplification and differentiation to an osteogenic phenotype, and degradation in register with bone regeneration, thus improving regenerative outcome with a 50 mg dose versus traditional rhBMP-2 dosing that are five times greater. 8 The minimal dose of rhBMP-2 supplementation of TyrPC scaffolds significantly enhanced bone formation. There is a profound patient benefit when a delivery system (i.e., bone biomimetic substitute) provides a physiological, calibrated dose of rhBMP-2.…”
Section: Discussionmentioning
confidence: 94%
“…By combining these three monomers, the resulting terpolymers can provide precise control of physical, chemical, biomechanical, and biological properties requisite for bone regeneration. 7,8 Polymers in combination with calcium phosphates (CPs) have been used as grafts for bone repair to improve bonescaffold integration, to enhance bone regeneration by promoting the deposition of hydroxyapatite in vivo, and to enhance adhesion and differentiation of osteoprogenitor cells. [9][10][11][12] CPs have been coated on the polymer surface or have been prepared as polymer-CP composites.…”
Section: Introductionmentioning
confidence: 99%
“…Several publications describe the development of a scaffold composition and architecture that promotes bone regeneration [1214]. These scaffolds are composed of a specific polymer composition (E1001(1k)), selected from a large library of tyrosine-derived polycarbonates.…”
Section: Resultsmentioning
confidence: 99%
“…Cylindrical scaffolds (8 mm diameter by 2 mm in height) were fabricated from a tyrosine-derived polycarbonate designated as E1001(1k) using a combination of lyophilization and particulate leaching and characterized as described previously [1214]. This particular polymer composition was selected from a large library of tyrosine-derived polycarbonates and was used to create bone regeneration scaffolds with both macro- and micropores having a size 212–450 mm and < 20 mm, respectively, and a compressive modulus of 2 MPa [14].…”
Section: Methodsmentioning
confidence: 99%
“…In order to demonstrate the feasibility of this approach, blends of two degradable tyrosine polycarbonates, poly(desaminotyrosyl-tyrosine ethyl ester carbonate) (pDTEc) and poly(desaminotyrosyl-tyrosine octyl ester carbonate) (pDTOc), were used to fabricate gas-foamed scaffold libraries. Tyrosine polycarbonates are being advanced for use in implantable biomedical devices such as hernia repair meshes, cardiovascular stents and bone tissue engineering scaffolds [25,26]. pDTEc and pDTOc have the same backbone but different side chains (Figure 2).…”
Section: Introductionmentioning
confidence: 99%